Director Dealing

RNS Number : 0427L

Renalytix AI PLC

19 December 2018

 

Renalytix AI plc

("RenalytixAI" or the "Company") 

Director Dealing

The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 103 pence per share.

Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.

Enquiries:

Renalytix AI plc	www.renalytixai.com
James McCullough, CEO	Via Walbrook PR or Tel: [phone]
N+1 Singer (Nominated Adviser & Broker)	Tel: [phone]
Aubrey Powell / James White / George Tzimas (Corporate Finance)
Tom Salvesen / Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone]
or [e-mail]
Paul McManus / Lianne Cawthorne	Mob: [phone]

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Harwood Capital LLP (Harwood) as investment manager to NASCIT
2	Reason for the notification
a)	Position/status	Christopher Mills, non-executive director of the issuer and director of North Altantic Smaller Companies Investment Trust plc (NASCIT)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Renalytix AI Plc
b)	LEI	213800NTOH3FK3WER551
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.25 pence each
	Identification code	GB00BYWL4Y04
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			103 pence	5,970
d)	Aggregated information	N/A
	- Aggregated volume
	- Price
e)	Date of the transaction	19 December 2018
f)	Place of the transaction	London Stock Exchange

 

END

 

 

DSHFKCDBFBDDQBD